Top Cancer Stocks in United States
Browse the largest United States companies in the world ranked by their Market Capitalization. Global Cancer Companies in United States market cap is $106.64B.
22 Jan 2025, 14:51 UTC
Companies: 160
🇺🇸101 | $0.44 | -2.87% | 38.14M | -90.56% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸102 | $1.99 | 1.02% | 33.76M | 70.09% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸103 | $3.13 | 3.48% | 33.51M | -26.30% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸104 | $1.22 | -1.61% | 33.44M | -76.40% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸105 | $1.15 | 3.60% | 31.66M | 85.19% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸106 | $0.70 | 0.00% | 31.14M | -75.18% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸107 | $3.38 | -1.17% | 30.04M | -37.06% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸108 | $0.62 | 1.57% | 29.75M | -74.57% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸109 | $1.93 | -1.58% | 26.40M | -77.31% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸110 | $0.87 | -7.76% | 24.22M | -25.17% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸111 | $0.56 | -1.76% | 23.92M | 4.43% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸112 | $0.87 | 4.06% | 21.45M | -87.90% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - | |
🇺🇸113 | $4.03 | -0.25% | 20.88M | 632.73% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸114 | $0.51 | 0.35% | 19.47M | -54.62% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸115 | $1.15 | 17.35% | 18.36M | 0.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸116 | $0.53 | 7.74% | 18.26M | -50.09% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸117 | $2.16 | -1.37% | 17.84M | -15.95% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸118 | $3.17 | -2.46% | 16.78M | -75.04% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸119 | $0.43 | -24.56% | 16.57M | 7.50% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸120 | $0.86 | 1.18% | 16.50M | -80.30% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸121 | $0.22 | 9.31% | 16.45M | -89.23% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - | |
🇺🇸122 | $0.40 | 2.84% | 16.10M | -86.34% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸123 | $2.36 | 0.00% | 15.72M | -59.17% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - | |
🇺🇸124 | $0.40 | -0.25% | 14.32M | -67.90% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸125 | $1.29 | 1.57% | 13.79M | -32.46% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸126 | $1.60 | 0.00% | 13.79M | -27.27% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸127 | $1.04 | -6.31% | 12.85M | 126.09% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸128 | $0.77 | 7.83% | 12.34M | 67.97% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸129 | $0.03 | 0.00% | 11.98M | -25.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸130 | $3.14 | 8.28% | 11.73M | -33.19% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸131 | $0.07 | 8.20% | 11.35M | -45.00% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - | |
🇺🇸132 | $0.45 | 0.44% | 11.35M | -35.97% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸133 | $2.17 | 16.04% | 10.60M | -24.91% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸134 | $0.45 | 0.44% | 10.48M | -81.69% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸135 | $0.23 | -2.25% | 10.14M | -82.88% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸136 | $2.20 | -1.35% | 10.06M | 201.37% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸137 | $0.20 | 5.26% | 9.77M | -54.55% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸138 | $0.95 | -2.36% | 9.03M | -39.10% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸139 | $0.05 | 0.00% | 8.44M | -71.89% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸140 | $0.15 | 18.11% | 7.81M | 3.45% | Underperform S&P500 YTD Benchamark | 🩹 Medical devices | - | |
🇺🇸141 | $0.82 | 3.16% | 7.66M | 16.43% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸142 | $0.91 | 2.27% | 7.64M | -49.49% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸143 | $1.27 | 4.55% | 7.51M | -50.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸144 | $1.02 | -2.40% | 5.98M | 82.88% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸145 | $1.49 | -5.10% | 5.87M | 125.08% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸146 | $0.20 | -0.49% | 5.28M | -97.34% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸147 | $0.70 | 16.45% | 5.08M | 16.83% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸148 | $1.08 | 0.93% | 4.88M | -39.66% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸149 | $2.09 | 0.00% | 4.70M | -13.64% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸150 | $0.83 | -2.35% | 4.36M | 36.63% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸151 | $0.19 | -5.56% | 4.00M | -84.92% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - | |
🇺🇸152 | $0.34 | 0.00% | 3.31M | -98.15% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸153 | $0.97 | 1.04% | 3.09M | -30.71% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸154 | $0.25 | -10.71% | 3.07M | -91.35% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸155 | $0.00 | 0.00% | 1.64M | -33.33% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸156 | $0.53 | 0.00% | 1.56M | -95.12% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸157 | $1.42 | -1.39% | 1.47M | -18.39% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸158 | $0.57 | 3.64% | 1.42M | -73.85% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸159 | $0.95 | 3.26% | 1.20M | -4.04% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - | |
🇺🇸160 | $0.01 | -3.85% | 1.19M | -99.39% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |